Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03019757 · ClinicalTrials.gov registry record

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

A clinical trial of Parkinson's Disease and Alzheimers Disease, sponsored by Douglas Scharre.

Recruiting
Registry status
76
Enrollment target
1
Study location

NCT03019757 is a study of Parkinson's Disease and Alzheimers Disease that is actively recruiting participants, run by Douglas Scharre. The registered enrollment target is 76 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03019757, a study of Parkinson's Disease and Alzheimers Disease, is actively recruiting participants, sponsored by Douglas Scharre.

RECRUITING
Registry status
76 participants
Enrollment target
1
Study location

Study Summary

The study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Lewy Body dementia, and Parkinsons' Disease.

Conditions Studied

Parkinson's Disease Alzheimers Disease Lewy Body Dementia

Interventions

  • RADIATION DaTscan
  • RADIATION F18-AV-45
  • RADIATION FDG-PET
  • GENETIC APOE genotype
  • PROCEDURE Polysomnogram

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2018-08-30
Est. Completion 2026-12

Sponsor

Douglas Scharre

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03019757

The ClinicalTrials.gov registry entry for NCT03019757 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (88% lower). The listed sponsor is Douglas Scharre, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Parkinson's Disease appearing as the primary indexed condition, and to 5 interventions - of which DaTscan is the first listed.

NCT03019757 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03019757 about?

NCT03019757 is a clinical study titled "Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease". The study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Lewy Body dementia, and Parkinsons' Disease.

What is the current status of trial NCT03019757?

This trial is currently recruiting. The enrollment target is 76 participants. The study started on 2018-08-30. Estimated completion is 2026-12.

What conditions does trial NCT03019757 study?

This clinical trial studies the following conditions: Parkinson's Disease, Alzheimers Disease, Lewy Body Dementia.

What interventions are being tested in trial NCT03019757?

The interventions under investigation include: DaTscan (RADIATION), F18-AV-45 (RADIATION), FDG-PET (RADIATION), APOE genotype (GENETIC), Polysomnogram (PROCEDURE).

Who is sponsoring clinical trial NCT03019757?

This trial is sponsored by Douglas Scharre, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03019757 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

Alzheimers Disease

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.